Unity Biotechnology, Inc.·4

Feb 15, 5:21 PM ET

Nguyen Alexander Hieu 4

4 · Unity Biotechnology, Inc. · Filed Feb 15, 2022

Insider Transaction Report

Form 4
Period: 2022-02-09
Nguyen Alexander Hieu
CLO and Head of Ops
Transactions
  • Award

    Common Stock, $0.0001 par value

    2022-02-09+45,83351,041 total
  • Award

    Stock Option (Right to Buy)

    2022-02-09+183,333183,333 total
    Exercise: $1.06Exp: 2032-02-09Common Stock (183,333 underlying)
Footnotes (3)
  • [F1]Represents Restricted Stock Units ("RSUs") one third of which vests on February 9, 2023 with the remaining RSUs vesting in equal quarterly installments over a two year period thereafter. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
  • [F2]Includes RSUs which vest over time measured from the grant date.
  • [F3]The underlying shares vest and become exercisable pursuant to the following schedule: One Third of the shares subject to the option vest on February 9, 2023 (the "Vesting Commencement Date"), and the remaining shares subject to the option vest in 24 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION